A stem-cell-based "organ-on-a-chip" model of ALS mimics early biological changes seen in the degenerative disease.

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

AUT00201, an oral small molecule, reduced the loss of motor neurons and eased motor symptoms in a mouse model of ALS, a study ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness as well as effective treatments.

The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...

Nov. 16, 2023 — Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested ...

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis NEJM DOI: 10.1056/NEJMoa1916945. ALS Drug Study Signals Progress Toward Treatment for Deadly Disease Wall Street Journal.

Amyotrophic lateral sclerosis (ALS) is a spectrum of neurodegenerative syndromes. 1,2 Classical, or Charcot, ALS affects approximately two-thirds of patients and is characterized by deterioration ...

Mar. 29, 2022 — Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder that affects as many as 30,000 people in the United States, with 5,000 new cases diagnosed each year. It ...

ALS can affect a person's ability to think and their behavior, but it does not affect their memory. Amyotrophic Lateral Sclerosis in Women vs. Men. ALS is more common in men than women. Women tend to ...

A team of researchers led by scientists at the University of Toronto (U of T) has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that the result ...